About Our People Legal Stuff Careers
FILE - In this Feb. 4, 2016 file photo, pharmaceutical chief Martin Shkreli speaks on Capitol Hill in Washington during the House Committee on Oversight and Reform Committee hearing on a decision by his former company, Turing Pharmaceuticals, to significantly raise the price of the anti-parasitic medication Daraprim. A bill awaits Vermont Gov. Peter Shumlin's signature in May 2016 that would make it the first state requiring drug companies to explain their price increases. The legislation would have regulators develop an annual list of up to 15 drugs that have seen the biggest price increases. Manufacturers then would have to justify the increases to the attorney general's office. (AP Photo/Susan Walsh, File)

Australian high schoolers created Martin Shkreli's price-hiked drugs for $20


A team of Australian high school students recreated a prime ingredient in the drug that Martin Shkreli's former company price-hiked to over $110,000, reports ABC News.  

How much did it cost them? Well, $20. 

The ingredient, called Pyrimethamine, is an active ingredient in Daraprim, which treats a parasitic infection that commonly occurs in people with weak immune systems, like pregnant women and HIV patients. 

In August 2015, Turing Pharmaceuticals acquired the rights to Daraprim and hiked the price per tablet from $13.50 to a whopping $750. 

This price hike inspired students at Sydney Grammar to try and create the drug cheaply. They worked with researchers at the University of Sydney via an online research-sharing platform called Open Source Malaria. 

Many on social media are still upset with Shkreli for the price hike. 

Like, really upset. 

Australian high schoolers created Martin Shkreli's price-hiked drugs for $20

For more, check out the 60 Second Circa. 

Read Comments
Facebook Twitter Instagram Pinterest Linked In List Menu Enlarge Gallery Info Menu Close Angle Down Angle Up Angle Left Angle Right Grid Grid Play Align Left Search Youtube Mail Mail Angle Down Bookmark